 |
|
|
| |
Islatravir Metabolic Outcomes in a Phase 2b Trial of Treatment-Naïve
Adults with HIV-1
|
| |
| |
CROI: Conference on Retroviruses and Opportunistic Infections; Boston, MA, USA; March
8-11, 2020
Reported by Jules Levin
Grace A. McComsey1; Jean-Michel Molina2; Yazdan
Yazdanpanah3; Edwin DeJesus4; Stephanie O. Klopfer5;
Anjana Grandhi5; Karen Eves5; Todd A. Correll5; Michael N. Robertson5; Carey Hwang5; George J. Hanna5; Peter Sklar5
1University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, USA; 2University of Paris Diderot and St-Louis Hospital, Paris, France; 3Bichat Hospital, Paris, France;
4Orlando Immunology Center, Orlando, FL, USA; 5Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
